54.14mg reported GHK-Cu content Janoshik #168141 Supplemental GHK-Cu 50mg PP2602-012AA endotoxin Janoshik endotoxin report #168137 Janoshik #168137 Supplemental GHK-Cu 50mg PP2602-012AB endotoxin Janoshik endotoxin report #168144 Janoshik #168144 Laboratory Research Use Only
While still clinically meaningful, this represents about two-thirds of the weight loss achieved with injectable formulations at optimal doses
P., Spyrou, G
Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M, Zangeneh F, Bush MA